<DOC>
	<DOCNO>NCT01080846</DOCNO>
	<brief_summary>This study evaluate side effect sublingual misoprostol ( 600 mcg ) first-line treatment primary postpartum hemorrhage ( PPH ) due suspect uterine atony .</brief_summary>
	<brief_title>Fever After Misoprostol Administration Treatment Primary Postpartum Hemorrhage</brief_title>
	<detailed_description>The study purpose confirm whether low , 600 mcg dose sublingual misoprostol reduce incidence elevate body temperature ( ≥40°C ) associate misoprostol . The study compare incidence high fever follow treatment 600 mcg sublingual misoprostol previously document rate use 800 mcg sublingual misoprostol . An additional line research investigate whether woman susceptible experience high fever follow misoprostol administration , whether genetic factor responsible misoprostol-induced fever .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Able willing give inform consent Vaginal delivery Postpartum hemorrhage due suspect uterine atony Oxytocin give 3rd stage labor Known allergy prostaglandin misoprostol Underwent cesarean section Postpartum hemorrhage NOT due suspect uterine atony Oxytocin NOT give 3rd stage labor Severe ill health Unable give inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Primary postpartum hemorrhage</keyword>
	<keyword>PPH</keyword>
	<keyword>uterine atony</keyword>
	<keyword>high fever</keyword>
	<keyword>hyperpyrexia</keyword>
</DOC>